Alma Mater Studiorum – University of Bologna (Italy) invites applications for the admission to the 38th PhD programme in Health and Technologies. (https://www.unibo.it/en/teaching/phd/2022-2023/health-and-technologies).
The research projects about biomechanics cover in silico methodologies, deep learning, experimental and computational characterization of biological tissues and biomaterials, and imaging techniques. Among the research projects advertised, you will find:
– I-BLOSSOM – Instrumented Biomarkers for LOngitudinal aSSessment Of Motor control development (Supervisor: Prof Stagni, email@example.com)
– Development and perspective validation of an in silico methodology for the prediction of bone fracture risk to be used as clinical support system (Supervisor: Prof. Viceconti, firstname.lastname@example.org)
– Biomechanical evaluation of knee mechanical behaviour and interface stresses with a new concept of alignment for total knee arthroplasty (NEW- KNEE) (Supervisor: Prof. Cristofolini, email@example.com)
– Computational modelling of vertebrae affected by metastasis for clinical diagnosis (Supervisor: Prof. Cristofolini, firstname.lastname@example.org)
PhD candidates are expected to operate in a multidisciplinary team of engineers, biomaterials science, medical physics, computer science, biologists and clinicians. Each project will be conjointly supervised by a supervisor active in the technology field and one in the clinical field.
More details can be found in (https://www.unibo.it/en/teaching/phd/2022-2023/attachments/38th-cycle-phd-programme-table-health-and-technologies/@@download/file/38_PhD%20Programme%20Table_Health_Technologies.pdf).
The online application must be submitted by June 9th, 2022 at 11.59 pm (CEST).
Three totally founded PhD scholarships are available.
If you would like to apply, contact the coordinator of the PhD programme (prof. Marco Viceconti, email@example.com) or the supervisor of the project you are interested in and join the University of Bologna for a wonderful research experience.